119 related articles for article (PubMed ID: 33907147)
1. Neonatal consequences of maternal exposure to the chikungunya virus: Case reports.
Fajardo TCG; Gazeta RE; Catalan DT; Mello AS; Silva ACBD; Bertozzi APAP; Santos GRD; Pinto CAL; Monteiro CO; Machado RRG; Oliveira DBL; Durigon EL; Passos SD
Medicine (Baltimore); 2021 Apr; 100(17):e25695. PubMed ID: 33907147
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya infection in pregnancy - reassuring maternal and perinatal outcomes: a retrospective observational study.
Foeller ME; Nosrat C; Krystosik A; Noel T; Gérardin P; Cudjoe N; Mapp-Alexander V; Mitchell G; Macpherson C; Waechter R; LaBeaud AD
BJOG; 2021 May; 128(6):1077-1086. PubMed ID: 33040457
[TBL] [Abstract][Full Text] [Related]
3. Pre and postnatal exposure to Chikungunya virus does not affect child neurodevelopmental outcomes at two years of age.
Waechter R; Ingraham E; Evans R; Cudjoe N; Krystosik A; Isaac R; Watts A; Noël T; Landon B; Fernandes M; Mapp-Alexander V; Suresh P; Mitchell G; Macpherson C; Gérardin P; LaBeaud AD
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008546. PubMed ID: 33017393
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island.
Gérardin P; Sampériz S; Ramful D; Boumahni B; Bintner M; Alessandri JL; Carbonnier M; Tiran-Rajaoefera I; Beullier G; Boya I; Noormahomed T; Okoï J; Rollot O; Cotte L; Jaffar-Bandjee MC; Michault A; Favier F; Kaminski M; Fourmaintraux A; Fritel X
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2996. PubMed ID: 25033077
[TBL] [Abstract][Full Text] [Related]
5. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
6. Experience of Perinatal and Neonatal Chikungunya Virus (CHIKV) Infection in a Tertiary Care Neonatal Centre during Outbreak in North India in 2016: A Case Series.
Kumar S; Agrawal G; Wazir S; Kumar A; Dubey S; Balde M; Yadav BS
J Trop Pediatr; 2019 Apr; 65(2):169-175. PubMed ID: 29893939
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
[TBL] [Abstract][Full Text] [Related]
8. Congenital and perinatal complications of chikungunya fever: a Latin American experience.
Torres JR; Falleiros-Arlant LH; Dueñas L; Pleitez-Navarrete J; Salgado DM; Castillo JB
Int J Infect Dis; 2016 Oct; 51():85-88. PubMed ID: 27619845
[TBL] [Abstract][Full Text] [Related]
9. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection.
Ramful D; Sampériz S; Fritel X; Michault A; Jaffar-Bandjee MC; Rollot O; Boumahni B; Gérardin P
J Infect Dis; 2014 Jun; 209(11):1726-30. PubMed ID: 24338351
[TBL] [Abstract][Full Text] [Related]
10. Vertical transmission of chikungunya virus: A systematic review.
Ferreira FCPADM; da Silva ASV; Recht J; Guaraldo L; Moreira MEL; de Siqueira AM; Gerardin P; Brasil P
PLoS One; 2021; 16(4):e0249166. PubMed ID: 33891622
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
Prince HE; Altrich ML; Nowicki MJ
Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
[TBL] [Abstract][Full Text] [Related]
12. Mother-to-child transmission of Chikungunya virus: A systematic review and meta-analysis.
Contopoulos-Ioannidis D; Newman-Lindsay S; Chow C; LaBeaud AD
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006510. PubMed ID: 29897898
[TBL] [Abstract][Full Text] [Related]
13. Chikungunya Virus Seroprevalence and Associated Factors among Hospital Attendees in Two States of Southwest Nigeria: A Preliminary Assessment.
Olajiga OM; Adesoye OE; Emilolorun AP; Adeyemi AJ; Adeyefa EO; Aderibigbe IA; Adejumo SA; Adebimpe WO; Opaleye OO; Sule WF; Oluwayelu DO
Immunol Invest; 2017 Aug; 46(6):552-565. PubMed ID: 28742401
[TBL] [Abstract][Full Text] [Related]
14. Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing.
Mendoza EJ; Robinson A; Dimitrova K; Mueller N; Holloway K; Makowski K; Wood H
Zoonoses Public Health; 2019 Dec; 66(8):909-917. PubMed ID: 31449360
[TBL] [Abstract][Full Text] [Related]
15. Vertical transmission of chikungunya virus: a worldwide concern.
Faria BS; da Silva LB; Avelar CFR; de Morais PAS; Bentes AA
Braz J Infect Dis; 2024; 28(3):103747. PubMed ID: 38723664
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Anti-Chikungunya Virus Antibodies in Children and Adults in Managua, Nicaragua, After the First Chikungunya Epidemic, 2014-2015.
Kuan G; Ramirez S; Gresh L; Ojeda S; Melendez M; Sanchez N; Collado D; Garcia N; Mercado JC; Gordon A; Balmaseda A; Harris E
PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004773. PubMed ID: 27322692
[TBL] [Abstract][Full Text] [Related]
17. Late Identification of Chikungunya Virus in the Central Nervous System of a 2-Month-Old Infant: Persistence of Maternal-Neonatal Infection?
Di Maio Ferreira FCPA; da Silva ASV; Bispo de Filippis AM; Brasil P
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):374-377. PubMed ID: 30657982
[TBL] [Abstract][Full Text] [Related]
18. Perinatal Outcomes in Vertically Infected Neonates During a Chikungunya Outbreak on the Island of Curaçao.
van Enter BJD; Huibers MHW; van Rooij L; Steingrover R; van Hensbroek MB; Voigt RR; Hol J
Am J Trop Med Hyg; 2018 Dec; 99(6):1415-1418. PubMed ID: 30328407
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.
Gérardin P; Barau G; Michault A; Bintner M; Randrianaivo H; Choker G; Lenglet Y; Touret Y; Bouveret A; Grivard P; Le Roux K; Blanc S; Schuffenecker I; Couderc T; Arenzana-Seisdedos F; Lecuit M; Robillard PY
PLoS Med; 2008 Mar; 5(3):e60. PubMed ID: 18351797
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort.
Yoon IK; Srikiatkhachorn A; Alera MT; Fernandez S; Cummings DAT; Salje H
Int J Infect Dis; 2020 Jun; 95():167-173. PubMed ID: 32247051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
